AKAN Akanda Corp.

6

Healthcare [ 3/11 ] | Drug Manufacturers—Specialty & Generic [ 23/154 ]

GB | NASDAQ | Stock

Price
$0.2725
Decreased by -11.93%
Dollar Volume
3.75 M
ADR%
34.94
Market Cap.
9.28 M
Shares Float
8.36 M
Shares Outstanding
34.04 M
Beta
0.00
Price / Earnings
-0.54
BPR
2.83
20D Range
0.15 0.64
50D Range
0.12 0.64
200D Range
0.12 12.30
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 21 24.07 K - -2.86 M -
Decreased by -11.89 K%
-
Dec 31, 20 274.00 - -5.99 K -
Decreased by -2.18 K%
-
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.